ThomasGeneGrossMD

Pediatric Hematology & Oncology • Phoenix, AZ

Professor of Pediatrics, University of Colorado School of Medicine

Join to view full profile

Dr. Gross is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Gross' full profile

Already have an account?

Office
1919 E Thomas Rd
Phoenix, AZ 85016
Phone+1 602-933-1000

Education & Training

University of MinnesotaFellowship, Pediatric Hematology/Oncology, 1991 - 1993
University of Nebraska Medical Center College of MedicineResidency, Pediatrics, 1988 - 1991
University of Nebraska College of MedicineClass of 1988

Certifications & Licensure

AZ State Medical License 2023 - 2025
CO State Medical License 2020 - 2025
OH State Medical License 1998 - 2021
MN State Medical License 1992 - 1994
American Board of Pediatrics Pediatric Hematology-Oncology

Clinical Trials

Cyclophosphamide, Rituximab, and Either Prednisone or Methylprednisolone in Treating Patients With Lymphoproliferative Disease After Solid Organ Transplantation Start of enrollment: 2004 Apr 01
Completed
Phase 2
Intergroup Trial for Children or Adolescents With Primary Mediastinal Large B-Cell Lymphoma: DA-EPOCH-Rituximab Evaluation Start of enrollment: 2012 Apr 01
Active, not recruiting
Phase 2
Intergroup Randomized Trial for Children or Adolescents With B-Cell Non Hodgkin Lymphoma or B-Acute Leukemia: Rituximab Evaluation in High Risk Patients Start of enrollment: 2011 Dec 01
Active, not recruiting
Phase 3
AR-42 and Decitabine in Treating Patients With Acute Myeloid Leukemia Start of enrollment: 2013 Sep 17
Completed
Phase 1
Join now to see all

Publications & Presentations

PubMed

The IPTA Nashville consensus conference on post-transplant lymphoproliferative disorders after solid organ transplantation in children: IV-consensus guidelines for the...
Upton D Allen, Arnaud G L'Huillier, Catherine M Bollard, Thomas G Gross, Robert J Hayashi
Pediatric Transplantation. 2024-08-01
Cost-effectiveness analysis alongside the inter-B-NHL ritux 2010 trial: rituximab in children and adolescents with B cell non-Hodgkin's lymphoma.
Béranger Lueza, Anne Aupérin, Charlotte Rigaud, Thomas G Gross, Marta Pillon
The European Journal of Health Economics. 2024-03-01
13 citations
The IPTA Nashville consensus conference on Post-Transplant lymphoproliferative disorders after solid organ transplantation in children: II-consensus guidelines for pre...
Michael Green, James E Squires, Richard E Chinnock, Patrizia Comoli, Lara Danziger-Isakov
Pediatric Transplantation. 2024-02-01

Other

Overview of pediatric non-Hodgkin lymphoma
Gross TG, Termuhlen AM
http://www.uptodate.com/contents/overview-of-pediatric-non-hodgkin-lymphoma
UpToDate, Wolters Kluwer Health - 2013-02-26

Grant Support

Phase II Trial--Treatment Of PTLD In Organ TransplantNational Cancer Institute1999
Phase II Trial--Treatment Of PTLD In Organ TransplantNational Cancer Institute1998